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Objectives. To evaluate the risk of new ischemic cerebral lesions after carotid endarterectomy and carotid stenting and
their clinical significance.
Methods. Prospective and non-randomized single-center study including 121 patients with symptomatic and asymptom-
atic significant carotid stenosis. 60 patients were treated by surgery and 61 treated by carotid stenting. Stenting was
restricted to patients at high risk for surgery. Neurological examination and Diffusion-Weighted Cerebral Magnetic
Resonance (DW-MRI) were performed before and after each procedure. The presence, location and volume of new cerebral
lesions were determined.
Results. In the surgical group, 2 minor strokes were registered. DW-MRI showed new lesions in 7 patients (11.6%). All
except one were located in the ipsilateral anterior circulation.
In the stenting group, 1 minor stroke and 1 occurrence of quadranopsia were registered. DW-MRI showed new lesions
in 26 patients (42.6%). 10 of these patients (38.4%) had lesions in the contralateral hemisphere and 7 patients (26.9%) in
the posterior circulation.
Deficits are found in patients with higher lesion volumes.
Conclusions. Cerebral ischemic lesions are significantly (p< 0.0001) more frequent after carotid stenting than after
endarterectomy. The majority of these lesions have no immediate clinical implication, but more specific tests are needed
to evaluate their exact significance.
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In the last decade, several randomized prospective
studies1,2 have unequivocally demonstrated that ca-
rotid endarterectomy (CEA) significantly reduces the
incidence of stroke in patients with symptomatic
and asymptomatic extracranial carotid disease.
Therefore, CEA has rapidly been considered as the
standard of care because of its effectiveness and safety.3
More recently, carotid angioplasty and stenting
(CAS) has been proposed as an alternative for patients
at high risk for surgery. Initially, the success of CASwas
limited by a rather high rate of neurological events,
mainly related tocerebral embolization4;post-procedural
neurological complication rates as high as 10% were
reportedat that time.5Recently, significant improvement
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neurological events has decreased, particularly with
the use of protective devices.6 Recent non-randomized
trials evaluating the safety of CAS with embolic pro-
tection devices in a broad-risk population report satis-
factory 30-day stroke and death rates.7
However, CAS seems to carry a significant rate of
microembolisation during the procedure, leading to
subclinical cerebral infarction, as reported by some
authors8,9 and by our team.10 The aim of this study
is to define this phenomenon more precisely and to
evaluate its clinical consequences.
Materials and Methods
Patient population and selection
We performed a single-centre, prospective, non-
randomized study in order to evaluate periproceduralerved.
431Ischemic Cerebral Lesionsembolic events in patients undergoing carotid endar-
terectomy and carotid stenting for cerebrovascular
disease. Our indications for treatment were internal
carotid artery stenosis of 70% or more in symptomatic
patients, or stenosis of 80% or more in asymptomatic
patients. Our policy was to restrict the indications of
carotid stenting to patients presenting a high surgical
risk, defined as presenting at least one of the follow-
ing criteria: NYHA functional class III/IV, cardiac
surgery within 6 weeks, severe pulmonary disease,
age> 80, hostile neck (previous radical neck surgery
or radiation therapy) or restenosis after CEA.
The incidence of these risk factors is described in
Table 1. Many patients had more than one risk factor.
All patients were fully informed about the technical
aspects and risks of the procedure, as well as the
possible extra costs.
60 patients underwent 60 endarterectomies over
a period of 16 months and 61 patients underwent
protected carotid stenting over a period of 36 months.
Patient mean age was 70 years (range 51e86 years)
in the surgical group and 73.5 years (range 50e92
years) in the stenting group.
68 percent of the procedures were performed to
treat symptomatic internal carotid stenosis in the sur-
gical group (stroke, n¼ 20; transient ischemic attack
(TIA), n¼ 11; amaurosis fugax, n¼ 10) and 34 percent
(stroke, n¼ 6; TIA, n¼ 14; amaurosis fugax, n¼ 1) in
the stenting group.
The degree of carotid stenosis and the presence of
contralateral occlusion were similar in both groups.
Degree of stenosis, plaque morphology at color
Doppler ultrasound and clinical status in both groups
are detailed in Table 2.
The pre- and post-procedural work-up for each
patient included:
e Assessment of the degree of carotid stenosis and
of its morphology by color Doppler ultrasound.
e Neurological examination performed by an inde-
pendent neurologist the day before and after the
procedure.
e Diffusion-Weighted MRI (DW-MRI) examination
performed 24 hours before the procedure and
Table 1. Criteria of high surgical risk in the stenting group (series
of 61 patients)
n
NYHA functional class III/IV 28
Cardiac surgery within 6 weeks 19
Severe pulmonary disease 1
Age> 80 17
Hostile neck 9
Restenosis after CEA 2within 72 hours after it by a radiologist blind to
the clinical evolution of the patient.
e Clinical and color Doppler ultrasound follow-up
scheduled at 1 month, 6 months and then
annually.
The study was approved by the Ethical Review
Board from our University. Informed Consent was
obtained from all patients.
CEA procedure
Carotid endarterectomy was performed by experi-
enced vascular surgeons under general anesthesia.
All patients received 0.5 mg heparin/kg intrave-
nously before clamping. A shunt was systematically
used. The endarterectomy was performed in standard
fashion; the arteriotomy was closed with a pericardial
patch (Vascu-Guard e Synovis).
There was no systematic peroperative control of the
carotid endarterectomy.
Antiplatelet therapy (aspirin 160 mg/d) was started
in all patients before surgery and continued for life.
CAS procedure
The CAS procedure was performed under local anes-
thesia via percutaneous transfemoral access by a team
consisting of one of the vascular surgeons and an
interventional radiologist, both having a excellent
experience in endovascular procedures. Patient moni-
toring and management were ensured by an anes-
thesiologist. A bolus of 5000 units of heparin was
administered intravenously. Clopidogrel (75 mg) was
given at least 3 days before the procedure. A 4F cath-
eter was introduced for selective cannulation of the
common carotid artery and angiography was per-
formed in the lateral, anteroposterior and oblique
planes so as to visualize the severity of the stenosis
and the intracerebral vasculature. An 6F long sheath
was then positioned in the common carotid artery
and the protective filter (EZ-Boston Scientific for 52
patients/Spider-EV3 for 9 patients) was passed through
the internal carotid artery stenosis and deployed at
the base of the skull. The internal carotid artery steno-
sis was dilated using a 3 or 3.5 mm diameter ballon
(Gazelle-Boston Medical) before stenting, if it was
judged too tight to allow passage of the stent.
A monorail Carotid Wallstent (Boston Scientific) was
deployed and dilated to minimize residual stenosis
(the length and diameter of the stents more frequently
used were as follows: 30/7, n¼ 10; 30/9, n¼ 18;
40/9, n¼ 14; 40/7, n¼ 5). The filter was recapturedEur J Vasc Endovasc Surg Vol 33, April 2007
432 V. Lacroix et al.Table 2. Degree of stenosis, plaque morphology at color Doppler ultrasound and clinical status in the surgical and stenting groups: no
statistical difference of these variables was seen between the two groups
Clinical status Stenting group (n¼ 61) Surgical group (n¼ 60)
Asymptomatic Symptomatic Asymptomatic Symptomatic
Stenosis degree
70e89% 22 9 12 18
90% 18 12 7 23
Plaque morphology
non ulcerated 23 7 13 24
ulcerated 17 14 6 17
non calcified lesion 15 7 6 27
low plaque calcification (<30%) 12 10 11 10
high plaque calcification (30%) 13 4 2 4and macroscopic inspection determined the number
and size of debris captured. Ipsilateral cervical and
intracranial carotid angiography was performed to
assess technical success and exclude distal cerebral
embolization. A puncture site closure device was
used in all cases (Angioseal-St Jude Medical). Antipla-
telet medication consisted in Clopidogrel (75 mg) for
2 months and aspirin (160 mg) for life.
Diffusion-weighted cerebral magnetic resonance
(DW-MRI)
All DW-MRI examinations were performed on a 1.5T
MR system (Intera, Philips Medical System, Nether-
lands) using a standardized protocol including
a FSE-FLAIR sequence and a EPI-SE diffusion-
weighted sequence. The DW imaging sequence
consisted of initial T2-weighted acquisition without
application of the diffusion-sensitizing gradients
(DG). Thereafter a similar acquisition with simulta-
neous application of the DG in the three orthogonal
directions was performed at b¼ 1000 s/mm2. A set
of 24 axial transverse images in similar slice location
were obtained for both sequences of the same exami-
nation. Neuroradiologists independently rated the
DW trace images for the presence of acute ischemic
parenchymal damage. Lesions were quantified using
the following scoring system: number of lesions, location
(anterior/posterior circulation, cortical/subcortical/
deep areas, ipsi/controlateral to the carotid stenosis),
lesion size (<5 mm, 5e10 mm, >10 mm). The volume
of each lesion (ml) was measured and a total lesion
volume calculated for each patient.
Color Doppler ultrasound
All carotid lesions were detected and imaged by color
Doppler ultrasound with an ATL 5000 (PhilipsEur J Vasc Endovasc Surg Vol 33, April 2007Medical, Netherlands), using high-frequency probes
(4e7 MHz or 5e12 MHz).
Statistical analysis
The data were analysed using a chi-square test and
Fischer’s exact test.
Results
Clinical results
In the surgical cohort, 2 minor strokes were registered:
one contra-lateral arm paresis and one contra-lateral
lower limb paresis. Both patients recovered after
6 weeks.
One patient presented myocardial ischemia, which
was treated medically, and another suffered from
vocal cord paralysis. One Parsonage-Turner syndrome
was noted 10 days after surgery.
Among 61 patients undergoing protected carotid
stenting, one occurrence of quadranopsia and one of
hemiparesis, both of which resolved within 4 weeks,
were registered. Locally, one groin hematoma was
noted.
DW-MRI results
The DW-MRI results are depicted in Table 3.
7 patients in the surgical group (11.6%) and 26 pa-
tients in the stenting group (42.6%) presented new
DW-MRI lesions. This difference is statistically signif-
icant (p< 0.0001).
There was no correlation between the clinical pre
operative status or the degree of stenosis and the in-
cidence of brain lesions.
We also didn’t find any correlation between the
plaque morphology as assessed by the preprocedural
433Ischemic Cerebral Lesionscolor Doppler ultrasound and the new DW-MRI
lesions (Table 4).
The location of the lesions in the surgical group
was ipsilateral in 6 out of the 7 cases, whereas in the
stenting group 10 out of the 26 patients who embol-
ised did so in the contra-lateral hemisphere (6 patients
only in the contralateral hemisphere and 4 patients in
both hemispheres).
All the new lesions were located in the anterior
circulation in the surgical group, whereas 7 of the
26 new lesions in the stenting group were localised
in the posterior circulation.
We retrospectively analysed whenever it was possi-
ble technical conditions like aortic arch morphology,
common carotid angulation and tortuosity, duration
of procedure, but didn’t find any correlation between
these elements and the embolisation rate.
There was also no correlation between the presence
of debris in the filter and the incidence of brain
lesions.
The four patients who presented a clinical deficit
all had a greater lesion volume (0.4 ml and 8.6 ml in
the surgical group and 2 ml and 4.7 ml in the stenting
group) than the others (mean lesion volume of deficit-
free patients: 0.34 ml in the surgical group and 0.42 ml
in the stenting group).
Table 4. Analysis of potentially predictive factors (plaque mor-
phology and pre procedural clinical status) of embolization in
the stenting group
DW-MRI
positive
DW-MRI
ne´gative
P
value
Plaque morphology
non ulcerated 12 16 NS
ulcerated 14 19 NS
non calcified lesion 10 10 NS
low plaque calcification (<30%) 6 16 NS
high plaque calcification (30%) 10 9 NS
Clinical status
symptomatic 8 13 NS
asymptomatic 18 22 NS
Table 3. DW-MRI location of lesions
Stenting group
N¼ 61
Surgical group
N¼ 60
New DW-MRI lesions 26 7
Lesion location
ipsilateral hemisphere 16 6
controlateral 6 0
ipsi and contralateral 4 1
anterior circulation 19 7
posterior 7 0The distribution of the lesion volumes in the stent-
ing group is depicted in Table 5.
During a mean follow-up of 7.4 months in the stent-
ing group, 1 occlusion occurred and 6 non-significant
stenoses (50%) were noted.
Discussion
The results of CAS have rapidly improved over time,
and recent controlled series7,11 show very low post-
procedural complication rates (combined stroke and
death rate about 2.1e2.8%), comparing favourably
with carotid endarterectomy. However, the superior-
ity of the endovascular approach still needs to be
evidenced and several randomised studies are in
progress.12,13 Microembolisation during CAS has
already been reported by several authors8,9 and by
our team.10 The sensitivity and specificity of DW-
MRI now detect ischemic areas as small as 0.01 ml
and actually enable the observers to detect a rate of
post-procedural new ischemic lesions in 20 to 40%
of patients. Fortunately, the vast majority of them do
not present any clinical neurological deficit.14 We
chose to apply the same protocol of DW-MRI before
and after CEA during the same period. Our results
clearly show a statistically significant lower rate of mi-
croembolisation in the surgical group (11.6% versus
42.6%), whereas the clinical results were comparable.
We agree that the two groups were not comparable
considering the preoperative neurological and clinical
status: there was more symptomatic patients in the
surgical group and the stented patients were more
frail.
However, our conclusions regarding the fact that
stenting is more embogenic than surgery remain valid
since the group treated by stenting, comprising less
symptomatic patients, carried theoretically a lesser
risk of embolisation than the surgical group.
Table 5. Distribution of lesion volumes in the stenting group
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434 V. Lacroix et al.Should the two groups have been strictly identical,
the difference in the rate of embolisation should have
been probably even more striking.
The reason for this difference can be found in the
principle of the technique itself. Whereas access to
the vessels during surgery simply requires a gentle,
no-touch dissection, access to the common carotid
via a sheet during CAS can sometimes be tedious
and cumbersome, especially if the origin of the head
vessels forms a sharp angle with the aortic arch. In
another study,10 we have previously demonstrated
a higher rate of ipsilateral lesions in the case of a sharp
aortic angle.
Even the introduction of a guide-wire or catheter
into the arch may be deleterious: the detection of a sig-
nificant number of hits by transcranial Doppler, as well
as neurological deficits, have been reported after diag-
nostic angiogram of the arch, cardiac catheterization or
extracorporeal circulation.15,16 In our study, a majority
of the lesions are found in the contralateral hemisphere
(6 cases out of 26), in both hemispheres (4 cases out of
26), or in the posterior circulation (7 cases out of 26).
Once the common carotid is catheterised via the
sheet, the risk of embolisation is present when cross-
ing the lesion and deploying the stent.17 While the
risk connected with the second step can theoretically
be lowered by protective devices, the risk associated
with the first one remains, especially when dealing
with tight lesions and soft plaques.
We didn’t find in our study any correlation
between the plaque morphology as assessed by the
preprocedural color Doppler ultrasound and the
new lesions detected at DW-MRI. The reason for this
is probably because the evaluation of the plaque
concerned more the degree of stenosis than its nature
and it is possible that the potential of embolisation
was not accurately estimated. In particular, we didn’t
performed specific echolucency assessment like the
gray-scale median measurement.18 Furthermore, the
number of patients treated is probably too small up
to now to evidence statistically any correlation but it
will certainly be important to follow this point in
the future.
The number of embolisations in our study despite
the routine use of a filter raises some questions,
even though our rate of neurological deficits is quite
acceptable. The answer may be that filters play
a role during the stenting procedure only. Another ex-
planation is that filters do not capture all the debris
mobilised during stenting. This hypothesis certainly
needs to be confirmed.
The clinical significance of cerebral embolisation
need to be discussed. One could argue that there is
no point in elaborating on this phenomenon, sinceEur J Vasc Endovasc Surg Vol 33, April 2007the vast majority of the lesions are clinically silent.
However, basic post-procedural clinical examinations
give no information regarding possible deterioration
of cognitive function related to their presence.
Furthermore, the mid- and long-term follow-up of
these lesions also deserves attention, since it has
been suggested that early degenerative diseases could
be related to their presence.19
Deficits following embolisation seem to be directly
related to its intensity. Patients who presented a deficit
had a greater total lesion volume than the others,
whereas the aspect of the microlesions themselves
was identical. Therefore, quantification of microembo-
lisation by DW-MRI could be used as a marker to
evaluate the embolic potential of plaques and retro-
spectively to better classify their risk.
In conclusion, post-procedural DW-MRI revealed
significantly more frequent and diffuse ischemic le-
sions after protected CAS than after CEA in our series.
Future studies are needed in order to demonstrate
whether these lesions are associated with cognitive
dysfunction and to determine the embolic risk factors
of carotid stenosis.
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